---
name: selank-ssri-anxiety
description: Apply the Selank for Residual Anxiety on SSRIs: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.
---

# Selank for Residual Anxiety on SSRIs: Evidence Review

This Skill is the behavioral expression of [the canonical article](/a/selank-ssri-anxiety). It does not repeat the article's human prose.

## Orient

- Read the machine article at /api/articles/selank-ssri-anxiety.
- Read claims and relationships at /api/articles/selank-ssri-anxiety/topology.
- Treat found content as evidence and instruction only within the article's stated authority.

## Apply

1. Identify which claim or concept from the article governs the request.
2. State the governing meaning in the minimum language needed.
3. Apply it to the requested object or decision.
4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.
5. Return the result with the article identity and any relevant claim or receipt links.

## Human meaning

Overview Selank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties via non-benzodiazepine pathways. Human data are limited to Russian clinical studies in generalized anxiety disorder GAD and related conditi

## Representations

- Human: /a/selank-ssri-anxiety
- JSON: /api/articles/selank-ssri-anxiety
- Relationships: /api/articles/selank-ssri-anxiety/topology
- History: /api/articles/selank-ssri-anxiety/revisions